Skip to main content
Lasa Supergenerics Limited logo

Lasa Supergenerics Limited — Investor Relations & Filings

Ticker · LASA ISIN · INE670X01014 LEI · 984500B9EA5EC3R2F726 BSE.NS Manufacturing
Open in API
Filings indexed 463 across all filing types
Latest filing 2021-08-18 Call Transcript
Country IN India
Listing BSE.NS LASA

About Lasa Supergenerics Limited

https://lasalabs.com/

Lasa Supergenerics Limited is a vertically integrated manufacturer specializing in Active Pharmaceutical Ingredients (APIs) for both veterinary and human health applications. The company focuses on the research, development, and production of high-quality chemical intermediates and APIs. Its core product portfolio includes a significant range of anthelmintics, such as Albendazole, Fenbendazole, and Ricobendazole, alongside other specialized therapeutic categories. Utilizing advanced manufacturing facilities and a dedicated research and development wing, the organization emphasizes cost-effective production processes and stringent quality control standards. Lasa Supergenerics Limited serves a global clientele, providing essential components for pharmaceutical formulations and animal health products through its expertise in complex chemical synthesis and large-scale manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held on June 4, 2021, discussing the financial results for the quarter and fiscal year ended March 31, 2021. It includes management commentary on financial performance, business outlook, product portfolio, and Q&A with investors. The presence of a full transcript of the call, including moderator and participant dialogue, confirms this is a Call Transcript (CT). The document length (15,000 characters) and content depth support this classification rather than a brief announcement or summary. There is no indication that this is a report publication announcement or a regulatory filing. Therefore, the appropriate classification is Call Transcript (CT).
2021-08-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 70% confidence The document is an announcement dated August 17, 2021, informing about an upcoming earnings call scheduled for August 20, 2021, to discuss the unaudited financial results for the quarter ended June 30, 2021 (Q1FY22). It includes details for joining the call and mentions that the financial results are available on the company's website. The document does not contain actual financial data or detailed financial statements but serves as a notification of the earnings call event. Therefore, it is not the earnings release itself but an announcement related to the earnings call. According to the filing definitions and rules, such a document is best classified as a Call Transcript (CT) category since it pertains to the earnings call event, but since this is only an announcement of the call and not the transcript, the closest appropriate category is Regulatory Filings (RNS) as a fallback for miscellaneous announcements that do not fit other categories. However, given the specific nature of the announcement about the earnings call, the best fit is Call Transcript (CT) with moderate confidence, acknowledging it is an announcement of the call rather than the transcript itself.
2021-08-17 English
Financial Result Updates
Regulatory Filings
2021-08-16 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a letter addressed to stock exchanges reporting the outcome of a board meeting held on August 14, 2021. It states that the Board of Directors approved the unaudited financial results along with a Limited Review Report for the quarter ended June 30, 2021. The letter attaches the financial results and the Limited Review Report and requests the exchanges to take the information on record. The document is short (1789 characters) and serves as an announcement of the approval and submission of the quarterly financial results and limited review report, rather than containing the full financial statements or detailed analysis itself. According to the rules, such announcements of financial results and limited review reports for a quarter are classified as Interim / Quarterly Reports (IR) if they contain substantive financial data. Since the letter mentions the approval of the unaudited financial results and the limited review report, and attaches these, it is consistent with an Interim / Quarterly Report filing. Therefore, the appropriate classification is IR with high confidence. Q1 2022
2021-08-14 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a notice of a scheduled Board Meeting to consider and approve unaudited financial results for the quarter ended June 30, 2021. It is an intimation to stock exchanges and shareholders about the upcoming board meeting, not the financial results report itself. The document is short (1680 characters) and serves as an announcement rather than containing substantive financial data or analysis. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and meeting notice, not an Interim Report (IR) or Earnings Release (ER).
2021-08-06 English
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate of non-disqualification of directors issued under SEBI Listing Obligations and Disclosure Requirements Regulations for the financial year ended March 31, 2021. It is a compliance certificate issued by the company secretary and secretarial auditors. The document is short (1402 characters) and serves as an attestation rather than a full report containing financial data or detailed disclosures. It does not contain financial statements or substantive financial analysis. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is a compliance-related filing and not a full report or announcement of a report.
2021-08-05 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.